Response of the lung to pulmonary insulin dosing in the rat model and effects of changes in formulation

Diabetes Technology and Therapeutics

Volumn 7, Issue 3, 2005, Pages 516-524

  Woods, T Cooper ^a   Zhang, Bin ^a   Mercogliano, Frank ^a   Dinh, Steven M ^a  

^a Emisphere Technologies Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INSULIN; ION CHANNEL; MESSENGER RNA; OCTANOIC ACID DERIVATIVE; TRANSCRIPTION FACTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DNA MICROARRAY; DRUG DELIVERY SYSTEM; DRUG FORMULATION; DRUG INSTILLATION; GLUCOSE BLOOD LEVEL; IMMUNE RESPONSE; INSULIN BLOOD LEVEL; LUNG INJURY; LUNG PARENCHYMA; MALE; NONHUMAN; PRIORITY JOURNAL; RAT;

ADENOSINE DEAMINASE; ANIMALS; BLOOD GLUCOSE; HYPOGLYCEMIC AGENTS; INSULIN; KINETICS; LUNG; MALE; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; RATS; RATS, SPRAGUE-DAWLEY; RNA, MESSENGER;

EID: 20544456114     PISSN: 15209156     EISSN: None     Source Type: Journal    
DOI: 10.1089/dia.2005.7.516     Document Type: Article

References (30)

1. Cefalu WT, Skyler JS, Kourides IA, Landschulz WH, Balagtas CC, Cheng S, Gelfand RA: Inhaled human insulin treatment in patients with type 2 diabetes mellitus. Ann Intern Med 2001;134:203-207.
2. Skyler JS, Cefalu WT, Kourides IA, Landschulz WH, Balagtas CC, Cheng SL, Gelfand RA: Efficacy of inhaled human insulin in type 1 diabetes mellitus: A randomised proof-of-concept study. Lancet 2001; 357:331-335.
3. Patton J, Platz R: Routes of delivery: Case studies (2). Pulmonary delivery of peptides and proteins for systemic action. Adv Drug Deliv Rev 1992;8:179-196.
4. Patton J, Trinchero P, Platz R: Bioavailability of pulmonary delivered peptides and proteins: Alpha interferon, calcitonins, and parathyroid hormones. J Control Release 1994;28:79-85.
5. Bensch KG, Dominguez E, Liebow AA: Absorption of intact protein molecules across the pulmonary air-tissue barrier. Science 1967;157:1204-1206.
6. Ruiz-Torres A, Melon J, Munoz FJ: Insulin stimulates collagen synthesis in vascular smooth muscle cells from elderly patients. Gerontology 1998;44:144-148.
7. Chai W, Chen J, Wang H, Shen J, Ma L, Ma X: The effects of glucose, insulin and oxidized low density lipoprotein on apoptosis in vascular endothelial cells. Chin Med J (Engl) 2000;113:903-906.
8. Thompson D, Harrison SP, Evans SW, Whicher JT: Insulin modulation of acute-phase protein production in a human hepatoma cell line. Cytokine 1991;3:619-626.
9. Campos SP, Baumann H: Insulin is a prominent modulator of the cytokine-stimulated expression of acute-phase plasma protein genes. Mol Cell Biol 1992;12: 1789-1797.
10. Aye M, Sheedy W, Harrison R, Thompson JS, Morice AH, Masson EA: Pulmonary vasodilation in the rat by insulin in vitro could indicate potential hazard for inhaled insulin. Diabetologia 2003;46:1199-1202.
11. Boyd MAP, Leone-Bay A, O'Toole DC, inventors; Emisphere Technologies, assignee: Compounds and compositions for delivering active agents. US Patent WO 01/51454 A1. July 2001.
12. Kalbag SS, Leone-Bay A, O'Shaughnessy C, Liu P, Dinh SM: Enhanced pulmonary delivery of insulin in a rat model. Presented at the Annual Meeting and Exposition of the American Association of Pharmaceutical Scientists, Indianapolis, IN, October 29-November 2, 2000.
13. Ashburner M, Ball CA, Blake JA, Botstein D, Butler H, Cherry JM, Davis AP, Dolinski K, Dwight SS, Eppig JT, Harris MA, Hill DP, Issel-Tarver L, Kasarskis A, Lewis S, Matese JC, Richardson JE, Ringwald M, Rubin GM, Sherlock G: Gene ontology. Tool for the unification of biology. The Gene Ontology Consortium. Nat Genet 2000;25:25-29.
14. Peraldi P, Filloux C, Emanuelli B, Hilton DJ, Van Obberghen E: Insulin induces suppressor of cytokine signaling-3 tyrosine phosphorylation through janus-activated kinase. J Biol Chem 2001;276:24614-24620.
15. Emanuelli B, Peraldi P, Filloux C, Chavey C, Freidinger K, Hilton DJ, Hotamisligil GS, Van Obberghen E: SOCS-3 inhibits insulin signaling and is up-regulated in response to tumor necrosis factor-alpha in the adipose tissue of obese mice. J Biol Chem 2001;276: 47944-47949.
16. Koren HS, Devlin RB, Graham DE, Mann R, McGee MP, Horstman DH, Kozumbo WJ, Becker S, House DE, McDonnell WF, Bromberg, PA: Ozone-induced inflammation in the lower airways of human subjects. Am Rev Respir Dis 1989;139:407-415.
17. Johnston CJ, Finkelstein JN, Gelein R, Oberdorster G: Pulmonary cytokine and chemokine mRNA levels after inhalation of lipopolysaccharide in C57BL/6 mice. Toxicol Sci 1998;46:300-307.
18. Dean DC: Expression of the fibronectin gene. Am J Respir Cell Mol Biol 1989;1:5-10.
19. Rahman I: Inflammation and the regulation of glutathione level in lung epithelial cells. Antioxid Redox Signal 1999;1:425-447.
20. Hallman M, Glumoff V, Ramet M: Surfactant in respiratory distress syndrome and lung injury. Comp Biochem Physiol A Mol Integr Physiol 2001;129: 287-294.
21. Balis JU, Paterson JF, Haller EM, Shelley SA, Montgomery MR: Ozone-induced lamellar body responses in a rat model for alveolar injury and repair. Am J Pathol 1988;132:330-344.
22. Voyno-Yasenetskaya TA, Dobbs LG, Erickson SK, Hamilton RL: Low density lipoprotein- and high density lipoprotein-mediated signal transduction and exocytosis in alveolar type II cells. Proc Natl Acad Sci USA 1993;90:4256-4260.
23. Liu L: Inhibition of lung surfactant secretion by KN-62, a specific inhibitor of the calcium- and calmodulin-dependent protein kinase II. Biochem Mol Biol Int 1998;45:823-830.
24. Barnard ML, Ridge KM, Saldias F, Friedman E, Gare M, Guerrero C, Lecuona E, Bertorello AM, Katz AI, Sznajder JI: Stimulation of the dopamine 1 receptor increases lung edema clearance. Am J Respir Crit Care Med 1999;160:982-986.
25. Lindenschmidt RC, Witschi H: Attenuation of pulmonary fibrosis in mice by aminophylline. Biochem Pharmacol 1985;34:4269-4273.
26. Amati B, Land H: Myc-Max-Mad: A transcription factor network controlling cell cycle progression, differentiation and death. Curr Opin Genet Dev 1994;4: 102-108.
27. Foretz M, Guichard C, Ferre P, Foufelle F: Sterol regulatory element binding protein-lc is a major mediator of insulin action on the hepatic expression of glucokinase and lipogenesis-related genes. Proc Natl Acad Sci USA 1999;96:12737-12742.
28. Dang AQ, Faas FH, Carter WJ: Effects of streptozotocin-induced diabetes on phosphoglyceride metabolism of the rat liver. Lipids 1984;19:738-748.
29. Rabinovici R, Kabir K, Chen M, Su Y, Zhang D, Luo X, Yang JH: ADAR1 is involved in the development of microvascular lung injury. Circ Res 2001;88:1066-1071.
30. Matsuoka T, Hirata M, Tanaka H, Takahashi Y, Murata T, Kabashima K, Sugimoto Y, Kobayashi T, Ushikubi F, Aze Y, Eguchi N, Urade Y, Yoshida N, Kimura K, Mizoguchi A, Honda Y, Nagai H, Narumiya S: Prostaglandin D2 as a mediator of allergic asthma. Science 2000;287:2013-2017.